ADAR1 mRNA quantification for predicting HSIL in persons with HIV and abnormal anal cytology.

Int J Cancer · 2025 · PMC12407038 · PMID 40704972

Europe PMC DOI

hedged sentence

0.0830

closest p · 1.7× alpha

0.0830

boldest claim

The sentences

showed a trendp = .083so close (0.05 < p ≤ 0.1)

Participants with false‐negative results showed a trend toward lower CD4 nadir counts compared with true negatives (median 102 [IQR, 51–290] vs. 268 [139–394] cells/μL, p = .083), and they had a significantly higher number of HPV genotypes (median, 5.0 [IQR, 5.0–9.0] vs. 3.0 [IQR, 1.0–5.0], p = .002) (Table S1 , Supporting Information).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.